Kamis, 1 Oktober 2026
iNarasikita — Mengubah Scroll Menjadi Senyuman
ıNarasikita1 Oktober 2026 · 35 mnt lalu

We have a drug that could transform HIV prevention. So why can’t millions get it?

A twice-yearly injection could revolutionise HIV prevention. But who gets access raises bigger questions about public money, pharmaceutical power, drug prices and shrinking global health funding. Al Jazeera’s Mikail Malik looks at the fight over access.

Bagikan:WhatsAppFacebook

Video Lainnya

Semua video →